Molecular Medicine Today

Germline gene transfer during gene therapy: reassessing the risks
pp. 371-371(1)
Author: Senior K.

Aggregation inhibitors: hope for Huntington's?
pp. 372-372(1)
Author: Sansom C.

Nanobacteria linked to kidney disease
pp. 373-373(1)
Author: Dorrell S.

Targeted transgenics from the creators of Dolly
pp. 374-374(1)
Author: Brooksbank C.

On the TRAIL to a new cancer therapy
pp. 374-374(1)
Author: Fricker J.

Knockout mice for dummies
pp. 375-375(1)
Author: Osborne L.R.

Gene therapy for HIV infection: safe if not efficacious
pp. 375-375(1)
Author: Caplen N.J.

The complexity of simple disorders
pp. 376-376(1)
Author: Evans K.L.

Complement depletion or blockade could save lives of sepsis victims
pp. 376-376(1)
Author: Gurwitz D.

Debating xenotransplantation - Xenotransplantation edited by J. Fishman, D. Sachs and R. Shaikh
pp. 377-377(1)
Author: Gunzburg W.H.

Marihuana and medicine: the debate persists - Marihuana and Medicine edited by G.G. Nahas, K.M. Sutin, D. Harvey and S. Agurell
pp. 378-378(1)
Author: Gurwitz D.

Does paraoxonase play a role in susceptibility to cardiovascular disease?
pp. 381-386(6)
Author: Aviram M.

The p53 family: same response, different signals?
pp. 387-392(6)
Author: Chen X.

Hepatitis C virus: current understanding and prospects for future therapies
pp. 393-399(7)
Authors: Rosen H.R.; Gretch D.R.

Gene therapy strategies to facilitate organ transplantation
pp. 400-405(6)
Authors: Deng S.; Brayman K.L.

The oncostatin M signalling pathway: reversing the neoplastic phenotype?
pp. 406-412(7)
Authors: Grant S.L.; Begley C.G.

An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling
pp. 413-414(2)
Authors: Lazner F.; Gowen M.; Kola I.